A recent study among high-risk patients found that pancreatic cancer screening through endoscopic ultrasound and/or MRI-based tests led to detection of smaller and earlier-stage cancers, and overall, seemed to result in longer survival. Patients with an inherited gene mutation that predisposes to pancreatic cancer and/or a family history of pancreatic cancer were considered to be high risk. This study contributes to the growing body of literature to show the possible benefits of pancreatic cancer screening to detect cancer early, when it is more treatable.
Blackford, et al. JAMA Oncol. 2024;10(8):1087-1096. PMID: 38959011.